ImmPACT Bio
Signal active
Organization
Contact Information
Overview
ImmPACT Bio USA Inc. is a cell therapy company aiming to develop potent and selective engineered T-cells for the treatment of solid tumors. The Company's technology enables targeting loss-of-gene features of solid tumor cells, sparing normal, healthy tissues.
About
Industries
Biotechnology, Life Science
Founded
2017
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
ImmPACT Bio headquartered in United States, North America, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $4.0B in funding across 24 round(s). With a team of 101-250 employees, ImmPACT Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - ImmPACT Bio, raised $8.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
1
Lead Investors
0
Total Funding Amount
$165.9M
Details
2
ImmPACT Bio has raised a total of $165.9M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2020 | Early Stage Venture | 18.0M | ||
| 2022 | Early Stage Venture | 139.9M |
Investors
ImmPACT Bio is funded by 22 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jim Tananbaum | - | FUNDING ROUND - Jim Tananbaum | 139.9M |
| ImmPACT Bio | - | FUNDING ROUND - ImmPACT Bio | 139.9M |
| Foresite Capital | - | FUNDING ROUND - Foresite Capital | 139.9M |
| ImmPACT Bio | - | FUNDING ROUND - ImmPACT Bio | 8.0M |
Recent Activity
There is no recent news or activity for this profile.